Trial Profile
Safety and efficacy study of intradetrusor injections of Botox [botulinum toxin A] for the treatment of urinary incontinence secondary to benign prostatic obstruction (BTX0621)
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Benign prostatic hyperplasia; Overactive bladder
- Focus Therapeutic Use
- 28 Jul 2007 New trial record.